Salary: Grade 7: £32,236 - £39,609 p.a.
An exciting opportunity is available for a Postdoctoral Researcher to join the Department of Oncology. You will contribute to the research of the Radiopharmacy and Molecular Imaging Group, led by Professor Bart Cornelissen, in collaboration with Dr Rebekka Hueting, Head of the radiochemistry/radiopharmacy core group by undertaking research into the development of radiolabelled agents for imaging of DNA damage in vitro and in vivo using PET imaging and in doing so, contribute to the Groups aim of the development of novel radiolabelled imaging agents for oncology
You will have (or be working towards) a PHD in organic chemistry, medicinal chemistry, PET radiochemistry, or equivalent science, with a strong background in preparative organic synthesis.
You will be able to demonstrate expertise in HPLC, NMR, IR, MS and other spectrometric identification of chemical compounds, also you will be able to display clear skill to organise, design and implement organic synthesis. You will be expected to aptly demonstrate how your previous fields of research, past intellectual and practical contributions can demonstrate your suitability to the above post.
Evidence will be sought of a deep understanding of the applicant's previous fields of research and evidence of independent intellectual and practical contributions to previous research projects, as indicators that such attributes can be brought to bear on the present project.
A Home Office personal licence (PIL) and experience of preclinical in vivo PET and/or SPECT imaging would be advantageous.
This is a full-time post and is available for 3 years in the first instance.
To apply for this role, please click on the Apply Now button in the link below. All applicants must complete an application form and upload a CV and supporting statement.
The closing date for applications is 12.00 noon on 30 November 2018. Interviews are likely to be held on 10 December 2018.